SCHEMBL8214582

SCHEMBL8214582

Bc1cccc(-c2nn(C)nc2-c2ccc(O)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ USP2 O75604 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ ESR1 P03372 6/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ RAD51 Q06609 2/20 0.38
▸ HSD17B2 P37059 2/20 0.38
▸ HSD17B1 P14061 1/20 0.38
▸ ABL1 P00519 2/20 0.36
▸ ABCB1 P08183 2/20 0.36
▸ BCR P11274 2/20 0.36
▸ ESR2 Q92731 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GMNN O75496 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8220878 0.73 ALOX15 (0.50) KMT2AMAPTUSP2NPSR1ESR1
SCHEMBL3270763 0.73 BRAF (0.50) KMT2AMAPTUSP2NPSR1HSD17B10
SCHEMBL8219529 0.70 MAPT (0.45) KMT2AMAPTUSP2NPSR1ESR1
SCHEMBL8205966 0.69 KMT2A (0.48) KMT2AMAPTUSP2NPSR1MEN1
SCHEMBL8214222 0.67 ADORA2A (0.53) KMT2AMEN1HSD17B2HSD17B1ABL1
SCHEMBL8213534 0.65 ESR1 (0.40) ESR1ABL1BCRESR2
SCHEMBL8223557 0.65 ESR1 (0.49) KMT2AMAPTUSP2NPSR1ESR1
SCHEMBL13350170 0.64 HSD17B1 (0.39) KMT2AESR1MEN1HSD17B2HSD17B1
SCHEMBL8214143 0.64 ALDH1A1 (0.54) KMT2AMAPTNPSR1MEN1KDM4E
SCHEMBL8013007 0.64 TDP1 (0.42) KMT2AMAPTNPSR1MEN1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021960-A2 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback